Ray S, Narayanan A, Vesterbacka J, Blennow O, Chen P, Gao Y
NPJ Biofilms Microbiomes. 2023; 9(1):104.
PMID: 38123600
PMC: 10733305.
DOI: 10.1038/s41522-023-00461-w.
Orillard E, Spehner L, Mansi L, Bouard A, Falcoz A, Lepiller Q
Front Immunol. 2023; 14:1160664.
PMID: 37334387
PMC: 10272422.
DOI: 10.3389/fimmu.2023.1160664.
Yoon J, Park B, Kim H, Choi S, Jung D
Nutrients. 2023; 15(7).
PMID: 37049424
PMC: 10097014.
DOI: 10.3390/nu15071584.
Ananya A, Holden K, Gu Z, Nettleton D, Mallapragada S, Wannemuehler M
Immun Ageing. 2023; 20(1):10.
PMID: 36895007
PMC: 9996592.
DOI: 10.1186/s12979-023-00332-0.
Pozo-Balado M, Bulnes-Ramos A, Olivas-Martinez I, Garrido-Rodriguez V, Lozano C, Alvarez-Rios A
Immun Ageing. 2023; 20(1):9.
PMID: 36879319
PMC: 9986663.
DOI: 10.1186/s12979-023-00334-y.
A comparative study of the COVID-19 vaccine efficacy among cancer patients: mRNA versus non-mRNA.
Rachman A, Iriani A, Sukrisman L, Rajabto W, Mulansari N, Lubis A
PLoS One. 2023; 18(3):e0281907.
PMID: 36857323
PMC: 9977046.
DOI: 10.1371/journal.pone.0281907.
Editorial: Innate immune responses to SARS-CoV-2 in infected and vaccinated individuals.
Saksena N, Reche P, Bonam S, Mancini N
Front Immunol. 2023; 14:1141405.
PMID: 36845086
PMC: 9945333.
DOI: 10.3389/fimmu.2023.1141405.
Adjusted COVID-19 booster schedules balance age-dependent differences in antibody titers benefitting risk populations.
Muller L, Andree M, Moskorz W, Drexler I, Hauka S, Ptok J
Front Aging. 2022; 3:1027885.
PMID: 36313184
PMC: 9596780.
DOI: 10.3389/fragi.2022.1027885.
Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in aged people.
Vitalle J, Perez-Gomez A, Jose Ostos F, Gasca-Capote C, Jimenez-Leon M, Bachiller S
JCI Insight. 2022; 7(17).
PMID: 35943812
PMC: 9536264.
DOI: 10.1172/jci.insight.161045.
Poly-γ-glutamic acid/Alum adjuvanted pH1N1 vaccine-immunized aged mice exhibit a significant increase in vaccine efficacy with a decrease in age-associated CD8 T cell proportion in splenocytes.
Yang J, Kim J, Kwak C, Poo H
Immun Ageing. 2022; 19(1):22.
PMID: 35606855
PMC: 9124744.
DOI: 10.1186/s12979-022-00282-z.
Innate Immune Responses of Vaccinees Determine Early Neutralizing Antibody Production After ChAdOx1nCoV-19 Vaccination.
Shen C, Yen C, Fu Y, Cheng C, Shen T, Chang P
Front Immunol. 2022; 13:807454.
PMID: 35145520
PMC: 8822242.
DOI: 10.3389/fimmu.2022.807454.
Dynamics of Antibody Response to BNT162b2 mRNA COVID-19 Vaccine: A 7-Month Follow-Up Study.
Olariu T, Ursoniu S, Marincu I, Lupu M
Medicina (Kaunas). 2021; 57(12).
PMID: 34946275
PMC: 8708569.
DOI: 10.3390/medicina57121330.
Immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in older residents of a long-term care facility: relation with age, frailty and prior infection status.
Seiffert P, Konka A, Kasperczyk J, Kawa J, Lejawa M, Maslanka-Seiffert B
Biogerontology. 2021; 23(1):53-64.
PMID: 34923608
PMC: 8684786.
DOI: 10.1007/s10522-021-09944-9.
Humoral anti-SARS-CoV-2 immune response after two doses of Comirnaty vaccine in nursing home residents by previous infection status.
Helle F, Moyet J, Demey B, Francois C, Duverlie G, Castelain S
Vaccine. 2021; 40(3):531-535.
PMID: 34893341
PMC: 8639399.
DOI: 10.1016/j.vaccine.2021.11.086.
The intestinal microbiota and improving the efficacy of COVID-19 vaccinations.
Chen J, Vitetta L, Henson J, Hall S
J Funct Foods. 2021; 87:104850.
PMID: 34777578
PMC: 8578005.
DOI: 10.1016/j.jff.2021.104850.
Change in age distribution of COVID-19 deaths with the introduction of COVID-19 vaccination.
Pastorino R, Pezzullo A, Villani L, Causio F, Axfors C, Contopoulos-Ioannidis D
Environ Res. 2021; 204(Pt C):112342.
PMID: 34748775
PMC: 8570444.
DOI: 10.1016/j.envres.2021.112342.
Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2.
Hernandez-Bello J, Morales-Nunez J, Machado-Sulbaran A, Diaz-Perez S, Torres-Hernandez P, Balcazar-Felix P
Vaccines (Basel). 2021; 9(9).
PMID: 34579284
PMC: 8472849.
DOI: 10.3390/vaccines9091047.
Older adults: panoramic view on the COVID-19 vaccination.
Andryukov B, Besednova N
AIMS Public Health. 2021; 8(3):388-415.
PMID: 34395690
PMC: 8334630.
DOI: 10.3934/publichealth.2021030.
Initial SARS-CoV-2 vaccination response can predict booster response for BNT162b2 but not for AZD1222.
Perkmann T, Perkmann-Nagele N, Mucher P, Radakovics A, Repl M, Koller T
Int J Infect Dis. 2021; 110:309-313.
PMID: 34332084
PMC: 8317449.
DOI: 10.1016/j.ijid.2021.07.063.
Review the safety of Covid-19 mRNA vaccines: a review.
Anand P, Stahel V
Patient Saf Surg. 2021; 15(1):20.
PMID: 33933145
PMC: 8087878.
DOI: 10.1186/s13037-021-00291-9.